Literature DB >> 3093446

Beta-lactam antibiotics and mycobacteria.

R Finch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3093446     DOI： 10.1093/jac/18.1.6

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  8 in total

1.  In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.

Authors:  P Hohl; M Salfinger; F M Kafader
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

2.  Imipenem for treatment of tuberculosis in mice and humans.

Authors:  Henry F Chambers; Joan Turner; Gisela F Schecter; Masae Kawamura; Philip C Hopewell
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

Review 3.  Targeting Phenotypically Tolerant Mycobacterium tuberculosis.

Authors:  Ben Gold; Carl Nathan
Journal:  Microbiol Spectr       Date:  2017-01

4.  Interplay of cell wall barrier and beta-lactamase activity determines high resistance to beta-lactam antibiotics in Mycobacterium chelonae.

Authors:  V Jarlier; L Gutmann; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

5.  Can penicillins and other beta-lactam antibiotics be used to treat tuberculosis?

Authors:  H F Chambers; D Moreau; D Yajko; C Miick; C Wagner; C Hackbarth; S Kocagöz; E Rosenberg; W K Hadley; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 6.  Have we realized the full potential of β-lactams for treating drug-resistant TB?

Authors:  Elizabeth Story-Roller; Gyanu Lamichhane
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

7.  Search for non-lactam inhibitors of mtb β-lactamase led to its open shape in apo state: new concept for antibiotic design.

Authors:  Amin Sagar; Nazia Haleem; Yaawar Mir Bashir
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

8.  Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions.

Authors:  Ben Gold; Jun Zhang; Landys Lopez Quezada; Julia Roberts; Yan Ling; Madeleine Wood; Wasima Shinwari; Laurent Goullieux; Christine Roubert; Laurent Fraisse; Eric Bacqué; Sophie Lagrange; Bruno Filoche-Rommé; Michal Vieth; Philip A Hipskind; Louis N Jungheim; Jeffrey Aubé; Sarah M Scarry; Stacey L McDonald; Kelin Li; Andrew Perkowski; Quyen Nguyen; Véronique Dartois; Matthew Zimmerman; David B Olsen; Katherine Young; Shilah Bonnett; Douglas Joerss; Tanya Parish; Helena I Boshoff; Kriti Arora; Clifton E Barry; Laura Guijarro; Sara Anca; Joaquín Rullas; Beatriz Rodríguez-Salguero; Maria S Martínez-Martínez; Esther Porras-De Francisco; Monica Cacho; David Barros-Aguirre; Paul Smith; Steven J Berthel; Carl Nathan; Robert H Bates
Journal:  ACS Infect Dis       Date:  2022-02-22       Impact factor: 5.084
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.